Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt

Cerebrovascular Diseases

Volumn 28, Issue 4, 2009, Pages 349-356

  Weimar, C ^a   Holle, D N ^a   Benemann, J ^a   Schmid, E ^b   Schminke, U ^c   Haberl, R L ^d   Diener, H C ^a   Goertler, M ^e  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Klinikum Stuttgart Burgerhospital   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d Abteilung fur Neurologie Stroke Unit Stad Krankenhaus Munchen Harlaching   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Ischemic stroke; Patent foramen ovale; Percutaneous device closure; Right to left shunt

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART RIGHT LEFT SHUNT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS DEVICE CLOSURE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SECONDARY PREVENTION; STROKE; SURGICAL EQUIPMENT;

ANTICOAGULANTS; CORONARY CIRCULATION; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; GERMANY; HEART CATHETERIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 67651003095     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229553     Document Type: Article

References (22)

1. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20
2. Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, Enriquez- Sarano M, Seward JB, Covalt JL, Sicks JD, Wiebers DO: Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999; 74: 862-869
3. Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000; 55: 1172-1179
4. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A: Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357: 2262-2268
5. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP: Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-2631
6. The European Stroke Organisation Executive Committee and the ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507
7. Slottow TL, Steinberg DH, Waksman R: Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation 2007; 116: 677-682
8. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41
9. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-1746
10. Jauss M, Zanette E: Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 2000; 10: 490-496
11. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Denning K, Engberding R, Sutherland GR, Vered Z, Erbel R, Visser CA, Lindert O, Hausmann D, Wenzlaff P: Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995; 91: 2785-2792
12. Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP: Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke 2004; 35: 2145-2149
13. Homma S, Sacco RL: Patent foramen ovale and stroke. Circulation 2005; 112: 1063-1072
14. Messe SR, Kasner SE: Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: Not to close. Circulation 2008; 118: 1999-2004
15. Windecker S, Meier B: Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation 2008; 118: 1989-1998
16. Serena J, Marti-Fabregas J, Santamarina E, Rodriguez JJ, Perez-Ayuso MJ, Masjuan J, Segura T, Gallego J, Davalos A: Recurrent stroke and massive right-to-left shunt: Results from the prospective Spanish Multicenter (CODICIA) study. Stroke 2008; 39: 3131-3136
17. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG: Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000; 31: 2407-2413. S
18. Messe S, Silverman I, Kizer J, Homma S, Zahn C, Gronseth G, Kasner SE: Practice parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042-1050 (Pubitemid 38456495)
19. Khairy P, O'Donnell CP, Landzberg MJ: Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003; 139: 753-760
20. Wohrle J: Closure of patent foramen ovale after cryptogenic stroke. Lancet 2006; 368: 350-352
21. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B: Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44: 750-758 (Pubitemid 39099567)
22. Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R: Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005; 101: 77-82